Company Biofarma Medical S.r.l. with Fiscal Code 24684470
recorded a turnover of 2024 of
3.096,
with a net profit of
-19.127
and having an average number of employees of
1.
The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Biofarma Medical S.r.l.
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
37.585
16.150
0
30.557
22.493
8.374
4.778
4.043
5.939
3.096
Total Income - EUR
37.587
40.679
403
30.618
22.508
44.474
9.391
996.867
283.911
3.098
Total Expenses - EUR
31.879
25.588
11.941
37.814
11.109
17.856
17.765
460.676
27.751
22.224
Gross Profit/Loss - EUR
5.708
15.090
-11.538
-7.197
11.399
26.617
-8.375
536.191
256.160
-19.127
Net Profit/Loss - EUR
5.562
14.156
-11.538
-7.502
11.174
26.063
-8.417
526.422
253.379
-19.127
Employees
0
1
1
1
1
1
2
2
2
1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -47.6%, from 5.939 euro in the year 2023, to 3.096 euro in 2024.
The Net Profit decreased by -251.963 euro, from 253.379 euro in 2023, to 0 in the last year.
Check the financial reports for the company - Biofarma Medical S.r.l.
Financial Rating - BIOFARMA MEDICAL S.R.L.
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Biofarma Medical S.r.l.
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Biofarma Medical S.r.l.
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Biofarma Medical S.r.l.
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Biofarma Medical S.r.l. - CUI 24684470
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
1.625
198
460.107
451.663
442.916
435.143
426.048
794
418
132
Current Assets
111.053
93.102
144.742
107.878
101.024
96.585
87.697
1.150.288
259.829
73.541
Inventories
41
47
47
76.414
74.889
75.502
73.830
73.262
72.349
71.800
Receivables
31.254
4.706
107.730
6.726
10.455
11.180
10.429
1.073.005
177.758
1.308
Cash
20.140
21.546
15.075
3.248
5.143
9.903
3.438
4.022
9.723
433
Shareholders Funds
49.557
53.942
41.491
33.228
43.758
68.992
59.045
518.028
253.043
63.706
Social Capital
45
45
44
43
42
41
40
41
40
40
Debts
63.120
39.358
563.358
526.313
500.182
462.736
454.700
633.054
7.205
9.967
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4646 - 4646"
CAEN Financial Year
4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
73.541 euro in 2024 which includes Inventories of
71.800 euro, Receivables of
1.308 euro and cash availability of
433 euro.
The company's Equity was valued at
63.706 euro, while total Liabilities amounted to
9.967 euro.
Equity decreased by -187.923 euro, from 253.043 euro in 2023, to 63.706 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Biofarma Medical S.r.l.